S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Sucampo Announces Acceptance of New Drug Submission for AMITIZA(R) (lubiprostone) by Health Canada (2014/12/30)|
|Sucampo Appoints John H. Johnson to Board of Directors (2014/12/15)|
|Robert J. Spiegel, M.D., FACP Joins Sucampo's Board of Directors (2015/1/21)|
|Sucampo Appoints Andrew Smith, FCMA, CGMA as CFO (2015/1/30)|
|AMITIZA(R) (lubiprostone) Mutual Recognition Procedure Closes With Recommendation for Approval in European Countries (2015/1/30)|
|Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2015 Leerink Global Healthcare Conference (2015/2/5)|
|Sucampo Announces Webcast of Its Presentation at the 2015 Cowen and Company Healthcare Conference (2015/2/22)|
|Sucampo Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2014 Earnings Call (2015/2/18)|
|Sucampo Announces Resolution of Par Pharmaceutical's ANDA for RESCULA(R) (2015/2/11)|
Click above to view more mutual fund data and stats for scmp - Sucampo Pharmaceuticals Inc Class A.